JP2021500882A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500882A5
JP2021500882A5 JP2020521861A JP2020521861A JP2021500882A5 JP 2021500882 A5 JP2021500882 A5 JP 2021500882A5 JP 2020521861 A JP2020521861 A JP 2020521861A JP 2020521861 A JP2020521861 A JP 2020521861A JP 2021500882 A5 JP2021500882 A5 JP 2021500882A5
Authority
JP
Japan
Prior art keywords
chimeric polypeptide
region
stalk
polypeptide according
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020521861A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056334 external-priority patent/WO2019079486A1/en
Publication of JP2021500882A publication Critical patent/JP2021500882A/ja
Publication of JP2021500882A5 publication Critical patent/JP2021500882A5/ja
Priority to JP2023118889A priority Critical patent/JP2023153866A/ja
Pending legal-status Critical Current

Links

JP2020521861A 2017-10-18 2018-10-17 スペーサーを含むポリペプチド組成物 Pending JP2021500882A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023118889A JP2023153866A (ja) 2017-10-18 2023-07-21 スペーサーを含むポリペプチド組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574061P 2017-10-18 2017-10-18
US62/574,061 2017-10-18
PCT/US2018/056334 WO2019079486A1 (en) 2017-10-18 2018-10-17 POLYPEPTIDE COMPOSITIONS COMPRISING SPACERS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023118889A Division JP2023153866A (ja) 2017-10-18 2023-07-21 スペーサーを含むポリペプチド組成物

Publications (2)

Publication Number Publication Date
JP2021500882A JP2021500882A (ja) 2021-01-14
JP2021500882A5 true JP2021500882A5 (https=) 2021-11-25

Family

ID=66096807

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020521861A Pending JP2021500882A (ja) 2017-10-18 2018-10-17 スペーサーを含むポリペプチド組成物
JP2023118889A Pending JP2023153866A (ja) 2017-10-18 2023-07-21 スペーサーを含むポリペプチド組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023118889A Pending JP2023153866A (ja) 2017-10-18 2023-07-21 スペーサーを含むポリペプチド組成物

Country Status (10)

Country Link
US (2) US11771718B2 (https=)
EP (1) EP3697438A4 (https=)
JP (2) JP2021500882A (https=)
KR (2) KR102742741B1 (https=)
CN (1) CN111511391B (https=)
AU (2) AU2018352984B2 (https=)
CA (1) CA3079264A1 (https=)
IL (2) IL316522A (https=)
SG (1) SG11202003543WA (https=)
WO (1) WO2019079486A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3820484A4 (en) * 2018-07-10 2022-05-04 Precigen, Inc. ROR-1 SPECIFIC CHIMERA ANTIGEN RECEPTORS AND USES THEREOF
JP7627080B2 (ja) * 2018-08-31 2025-02-05 シアトル チルドレンズ ホスピタル ディー/ビー/エイ シアトル チルドレンズ リサーチ インスティテュート B7h3キメラ抗原受容体を含む方法および組成物
SG11202104287RA (en) * 2018-11-06 2021-05-28 Univ Washington Chimeric antigen receptor memory-like (carml) nk cells and methods of making and using same
WO2020214937A1 (en) * 2019-04-19 2020-10-22 Allogene Therapeutics, Inc. Antibodies against 4g7-derived chimeric antigen receptors
EP3962527A4 (en) 2019-04-30 2023-11-01 Senti Biosciences, Inc. CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
SE544015C2 (en) * 2019-06-18 2021-11-02 Tx Medic Ab Allogenic car-t cell therapy
CN114222763A (zh) * 2019-06-19 2022-03-22 尤利乌斯·马克西米利安维尔茨堡大学 在嵌合抗原受体设计中实现的超模块化IgG3间隔区结构域和多功能位点
CN114761084B (zh) * 2019-09-24 2023-10-27 加利福尼亚大学董事会 具有铰链结构域的Notch受体
CN112111014A (zh) * 2020-09-22 2020-12-22 廖文强 一种抗氧化嵌合型抗原受体和免疫细胞
MX2023008115A (es) * 2021-01-11 2023-09-11 Precigen Inc Terapia con receptores quiméricos.
US20240108653A1 (en) * 2021-02-05 2024-04-04 University Of Utah Research Foundation Compositions and methods for treating with car cells
AU2022227686A1 (en) 2021-02-25 2023-07-27 Lyell Immunopharma, Inc. Ror1 targeting chimeric antigen receptor
EP4334361A1 (en) 2021-05-05 2024-03-13 Immatics Biotechnologies GmbH Antigen binding proteins specifically binding prame
TW202521564A (zh) * 2023-08-14 2025-06-01 美商英特利亞醫療公司 用於基於細胞之療法的cd70 car-t組合物及方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3083324A1 (en) * 2010-03-05 2011-09-09 The Johns Hopkins University Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
ES2754394T3 (es) 2010-09-08 2020-04-17 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Receptores de antígenos quiméricos con una región bisagra optimizada
WO2013059593A1 (en) 2011-10-20 2013-04-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-cd22 chimeric antigen receptors
US20140370012A1 (en) * 2012-01-27 2014-12-18 Gliknik Inc. Fusion proteins comprising igg2 hinge domains
CA2881981A1 (en) 2012-08-20 2014-02-27 Fred Hutchinson Cancer Research Center Method and compositions for cellular immunotherapy
EP3783098A1 (en) 2013-05-14 2021-02-24 Board Of Regents, The University Of Texas System Human application of engineered chimeric antigen receptor (car) t-cells
US10287354B2 (en) 2013-12-20 2019-05-14 Novartis Ag Regulatable chimeric antigen receptor
CN113354744A (zh) 2013-12-20 2021-09-07 弗雷德哈钦森癌症研究中心 带标签的嵌合效应分子及其受体
EP3656864A1 (en) * 2014-02-14 2020-05-27 Board of Regents, The University of Texas System Chimeric antigen receptors and methods of making
JP6556156B2 (ja) * 2014-02-27 2019-08-07 ユーシーエル ビジネス ピーエルシー Aprilバリアント
CA2945320A1 (en) 2014-04-10 2015-10-15 Seattle Children's Hospital (dba Seattle Children's Research Institute) Drug regulated transgene expression
SI3194434T1 (sl) 2014-09-15 2019-11-29 Molmed Spa Himerni antigenski receptorji
JP2017531430A (ja) * 2014-10-07 2017-10-26 セレクティスCellectis Carによって誘導される免疫細胞の活性を調節するための方法
WO2016168769A1 (en) 2015-04-15 2016-10-20 The California Institute For Biomedical Research Chimeric receptor t cell switches for her2
EP4424326A3 (en) * 2015-06-10 2024-11-13 ImmunityBio, Inc. Modified nk-92 cells for treating cancer
WO2016210447A1 (en) 2015-06-26 2016-12-29 University Of Southern California Masking chimeric antigen receptor t cells for tumor-specific activation
WO2017027291A1 (en) 2015-08-07 2017-02-16 Seattle Children's Hospital (dba Seattle Children's Research Institute) Bispecific car t-cells for solid tumor targeting
EP3708587B1 (en) * 2015-11-27 2024-05-22 Cartherics Pty. Ltd. Genetically modified cells and uses thereof
MA45341A (fr) 2016-06-06 2019-04-10 Hutchinson Fred Cancer Res Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
SG11201810640RA (en) * 2016-06-08 2018-12-28 Intrexon Corp Cd33 specific chimeric antigen receptors
KR20190102259A (ko) * 2017-01-10 2019-09-03 인트렉손 코포레이션 신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절
EP3635132A4 (en) * 2017-06-07 2021-05-26 Intrexon Corporation EXPRESSION OF NOVEL CELL MARKERS
US11319380B2 (en) * 2018-06-04 2022-05-03 Precigen, Inc. MUC16 specific chimeric antigen receptors and uses thereof
WO2020014285A2 (en) * 2018-07-09 2020-01-16 Intrexon Corporation Fusion constructs and methods of using thereof
EP3820484A4 (en) * 2018-07-10 2022-05-04 Precigen, Inc. ROR-1 SPECIFIC CHIMERA ANTIGEN RECEPTORS AND USES THEREOF
EP4178680A4 (en) * 2020-07-10 2024-07-31 Precigen, Inc. FUSION CONSTRUCTS AND THEIR METHODS OF USE
MX2023008115A (es) * 2021-01-11 2023-09-11 Precigen Inc Terapia con receptores quiméricos.

Similar Documents

Publication Publication Date Title
JP2021500882A5 (https=)
EP3472205B1 (en) Chimeric antigen receptor
JP2023091037A (ja) Gタンパク質共役受容体を標的化するキメラ抗原受容体およびその使用
JP2020511136A5 (https=)
JP2022109953A5 (https=)
JP2022113880A5 (https=)
JP2023085527A5 (https=)
JP2024059628A (ja) Cd19指向性キメラ抗原受容体および免疫療法におけるその使用
RU2019133199A (ru) Улучшенные форматы антигенсвязывающего рецептора
JP2018508219A5 (https=)
JP7566628B2 (ja) キメラ抗原受容体を発現する免疫細胞
JP2019150066A5 (https=)
JP2017507917A5 (https=)
US20190023764A1 (en) Car having replicated binding motifs in a co-stimulatory domain
JP2020511949A5 (https=)
JP2016534717A5 (https=)
RU2017133637A (ru) Иммуномодулирующие слитые белки и пути их применения
RU2018118652A (ru) Химерные конструкции антитело/т-клеточный рецептор и их применения
Murad et al. Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies
JP2018516092A5 (https=)
RU2017102769A (ru) EGFRvIII СПЕЦИФИЧЕСКИЕ ХИМЕРНЫЕ АНТИГЕННЫЕ РЕЦЕПТОРЫ ДЛЯ ИММУНОТЕРАПИИ РАКА
JP2021514631A5 (https=)
JP2018532407A5 (https=)
JP2018525006A5 (https=)
JPWO2020181094A5 (https=)